…and Boehringer Ingelheim’s broad drug discovery and clinical development capabilities. Aurobac has launched with €75 million in funding with Boehringer Ingelheim its lead investor. Official comments Werner Lanthaler, CEO of…

A drug candidate for heart attacks which contains venom from a deadly spider has moved closer to clinical trials due to investment of $23 million. A research team at the…

…build our understanding of the gaps in diagnosis and clinical care pathways, and to set ambitious quality standards to give patients better access to medicines with the potential to prevent…

…conduct collaborative projects to enhance patient stratification for other biopharma and medtech companies’ clinical-stage R&D programmes. Official comments “Longitudinal multi-omics data combined with deep clinical phenotyping is essential to developing…

Molecular genetics company Mainz Biomed has enrolled its first patient in an international clinical study assessing the potential combination of gene expression (mRNA) biomarkers with a diagnostic test for colorectal…

…Care Excellence (NICE). US launches trial for potential universal flu vaccine The National Institutes of Health (NIH) has launched a Phase I clinical trial for a potential universal flu vaccine….

…M.D. “The scientific community is making progress on this pressing global health priority. The BPL-1357 candidate influenza vaccine being tested in this clinical trial performed very well in pre-clinical studies…

…potentially directing them towards appropriate clinical trials. More so, the partnership will look at developing more robust lab tests and models of disease to enable scientists to test theories about…

Clinical diagnostics company Novacyt has launched a polymerase chain reaction (PCR) monkeypox assay in response to the recent outbreak of the virus non-endemic countries. The company’s monkeypox assay is for…

…of 75.1% against symptomatic infection, and 93.2% in Omicron confirmed symptomatic cases. Earlier this year, Sanofi reported positive data from two trials conducted with its new Covid-19 booster vaccine candidate…